...
首页> 外文期刊>Pediatric cardiology >Regression of pulmonary vascular disease after therapy of abernethy malformation in visceral heterotaxy
【24h】

Regression of pulmonary vascular disease after therapy of abernethy malformation in visceral heterotaxy

机译:小儿畸形内脏异位症治疗后肺血管疾病的消退

获取原文
获取原文并翻译 | 示例
           

摘要

A 1-year-old boy who had left isomerism and corrected transposition of the great arteries (c-TGA) with moderate-sized ventricular septal defect, severe pulmonary artery hypertension (PAH), and pulmonary vascular disease with significant right-to-left shunting received a diagnosis of type 2 Abernethy malformation, which was partly responsible for disproportionate PAH in the child. The malformation was treated by plugging of the portosystemic shunt. Follow-up cardiac catheterization on sildenafil demonstrated significant left-to-right shunting (2.16:1) and a fall in pulmonary vascular resistance, making surgical correction possible. This case highlights the importance of searching for additional rare causes of PAH in patients with congenital heart diseases when the degree of pulmonary hypertension is disproportional to the defect size.
机译:一个1岁男孩,左异构,纠正了中型室间隔缺损,严重的肺动脉高压(PAH)和大从右到左的肺血管疾病的大动脉移位(c-TGA)分流术被诊断出2型Abernethy畸形,部分原因是造成儿童PAH比例过高。通过堵塞门体系统分流器治疗畸形。西地那非的后续心脏导管检查显示左右分流明显(2.16:1),肺血管阻力下降,使得手术矫正成为可能。当肺动脉高压的程度与缺损的大小成比例时,这种情况突出了在先天性心脏病患者中寻找PAH的其他罕见原因的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号